Cash flow Hubei Jumpcan Pharmaceutical Co., Ltd.

Equities

600566

CNE0000018X6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 13/01/2026			5-day change	1st Jan Change
26.08 ^CNY	0.00%		-1.44%	-0.84%

04/01	Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 24, 2025.	CI
24/11	Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	CI

9751188a87c5e30b466a573a.l26vWVtxEQv-Z22EoF-4pizDB2d0tnIhyR-7tfBus9Y.yBnsGAEES2e7VTT3zAjx3nO6TlAa1TFqmErOjJsd3Y-hKeYJDgQoX7kyLA

Published financial data: HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	615.07Cr	761.75Cr	897.65Cr	963.8Cr	799.65Cr
Other Revenues, Total	1.43Cr	1.3Cr	1.99Cr	1.65Cr	2.04Cr
Total Revenues	616.5Cr	763.05Cr	899.64Cr	965.45Cr	801.69Cr
Cost of Goods Sold, Total	113.03Cr	127.66Cr	153.74Cr	178.4Cr	166.64Cr
Gross Profit	503.47Cr	635.39Cr	745.9Cr	787.05Cr	635.05Cr
Selling General & Admin Expenses, Total	329.96Cr	403.07Cr	447.7Cr	437.93Cr	338.68Cr
Provision for Bad Debts	62.26L	82.81L	3.6Cr	-30.43L	-2.22Cr
R&D Expenses	24Cr	52Cr	55Cr	46Cr	44Cr
Other Operating Expenses	9.99Cr	12Cr	14Cr	15Cr	12Cr
Other Operating Expenses, Total	364.95Cr	468.34Cr	520.51Cr	498.69Cr	392.48Cr
Operating Income	138.52Cr	167.06Cr	225.39Cr	288.36Cr	242.57Cr
Interest Expense, Total	-3.3Cr	-3.49Cr	-3.04Cr	-1.76Cr	-2.73Cr
Interest And Investment Income	8.3Cr	17Cr	18Cr	36Cr	35Cr
Net Interest Expenses	5Cr	14Cr	15Cr	34Cr	33Cr
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	-6L	-4L	-11.95L	-8L	-10.29L
EBT, Excl. Unusual Items	143.46Cr	180.67Cr	240.55Cr	322.3Cr	275.02Cr
Gain (Loss) On Sale Of Investments	2.09Cr	11Cr	-73.16L	1.46Cr	9.92Cr
Gain (Loss) On Sale Of Assets	33.46L	7L	52.17L	1L	2L
Asset Writedown	-8L	-4L	-5L	-10.89L	-3L
Other Unusual Items	2.54Cr	2.9Cr	11Cr	6.04Cr	13Cr
EBT, Incl. Unusual Items	148.35Cr	195.04Cr	250.79Cr	329.71Cr	297.82Cr
Income Tax Expense	21Cr	23Cr	34Cr	47Cr	44Cr
Earnings From Continuing Operations	127.72Cr	171.72Cr	217.17Cr	282.71Cr	253.67Cr
Net Income to Company	127.72Cr	171.72Cr	217.17Cr	282.71Cr	253.67Cr
Minority Interest	-	19.59L	-10L	-42.82L	-51.52L
Net Income - (IS)	127.72Cr	171.92Cr	217.08Cr	282.28Cr	253.16Cr
Net Income to Common Incl Extra Items	127.72Cr	171.92Cr	217.08Cr	282.28Cr	253.16Cr
Net Income to Common Excl. Extra Items	127.72Cr	171.92Cr	217.08Cr	282.28Cr	253.16Cr
Per Share Items
Net EPS - Basic	1.53	1.94	2.44	3.08	2.76
Basic EPS - Continuing Operations	1.53	1.94	2.44	3.08	2.76
Basic Weighted Average Shares Outstanding	83Cr	89Cr	89Cr	92Cr	92Cr
Net EPS - Diluted	1.53	1.91	2.39	3.08	2.76
Diluted EPS - Continuing Operations	1.53	1.91	2.39	3.08	2.76
Diluted Weighted Average Shares Outstanding	83Cr	90Cr	91Cr	92Cr	92Cr
Normalized Basic EPS	1.07	1.28	1.69	2.19	1.87
Normalized Diluted EPS	1.07	1.26	1.65	2.19	1.87
Dividend Per Share	0.45	0.68	0.88	1.3	2.09
Payout Ratio	78.98	23.81	27.89	29.16	48.1
Supplemental Items
EBITDA	166.16Cr	195.9Cr	255.61Cr	318.04Cr	272.68Cr
EBITA	139.81Cr	168.55Cr	227.2Cr	290.35Cr	244.79Cr
EBIT	138.52Cr	167.06Cr	225.39Cr	288.36Cr	242.57Cr
EBITDAR	166.68Cr	196.41Cr	256.14Cr	318.62Cr	273.29Cr
Total Revenues (As Reported)	616.5Cr	763.05Cr	899.64Cr	965.45Cr	801.69Cr
Effective Tax Rate - (Ratio)	13.91	11.96	13.41	14.26	14.83
Total Current Taxes	20Cr	23Cr	33Cr	46Cr	42Cr
Total Deferred Taxes	56.21L	69.69L	49.59L	59.63L	2.11Cr
Normalized Net Income	90Cr	113.11Cr	150.24Cr	201.01Cr	171.37Cr
Interest on Long-Term Debt	-	3L	1L	27.81T	1L
Supplemental Operating Expense Items
Marketing Expenses	218.29Cr	286.36Cr	362.42Cr	367.17Cr	263.96Cr
Selling and Marketing Expenses	300.96Cr	371.38Cr	411.27Cr	400.65Cr	295.41Cr
General and Administrative Expenses	29Cr	32Cr	36Cr	37Cr	43Cr
Research And Development Expense From Footnotes	25Cr	75Cr	55Cr	48Cr	46Cr
Net Rental Expense, Total	52.02L	50.87L	52.46L	58.15L	61.67L
Imputed Operating Lease Interest Expense	23.32L	23.04L	24.76L	10.97L	13.95L
Imputed Operating Lease Depreciation	28.7L	27.83L	27.7L	47.17L	47.71L
Stock-Based Comp., G&A Exp. (Total)	-	-	46.39L	1.33Cr	1.73Cr
Total Stock-Based Compensation	-	-	46.39L	1.33Cr	1.73Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	295.92Cr	381.9Cr	481.89Cr	773.8Cr	666.94Cr
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	125.8Cr	167.5Cr	304.46Cr	317.83Cr	516.1Cr
Total Cash And Short Term Investments	421.71Cr	549.4Cr	786.35Cr	1.09TCr	1.18TCr
Accounts Receivable, Total	203.17Cr	218.29Cr	285.03Cr	278.16Cr	225.75Cr
Other Receivables	1.03Cr	1.2Cr	1.72Cr	1.5Cr	1.25Cr
Total Receivables	204.2Cr	219.49Cr	286.75Cr	279.66Cr	227Cr
Inventory	28Cr	38Cr	39Cr	49Cr	57Cr
Prepaid Expenses	-	-	-	-	-
Other Current Assets, Total	3.81Cr	5.83Cr	5.42Cr	3.25Cr	3.26Cr
Total Current Assets	657.57Cr	812.28Cr	1.12TCr	1.42TCr	1.47TCr
Gross Property Plant And Equipment	421.54Cr	436.52Cr	445.47Cr	478.8Cr	484.19Cr
Accumulated Depreciation	-107.45Cr	-133.12Cr	-159.86Cr	-186.55Cr	-213.56Cr
Net Property Plant And Equipment	314.09Cr	303.4Cr	285.61Cr	292.25Cr	270.63Cr
Long-term Investments	16Cr	33Cr	33Cr	39Cr	46Cr
Goodwill	17Cr	17Cr	17Cr	17Cr	17Cr
Other Intangibles, Total	28Cr	28Cr	32Cr	31Cr	31Cr
Deferred Tax Assets Long-Term	4.26Cr	5.73Cr	6.22Cr	4.54Cr	4.18Cr
Deferred Charges Long-Term	2.37Cr	1.32Cr	38.7L	1.19Cr	23.85L
Other Long-Term Assets, Total	13Cr	13Cr	6.21Cr	6.22Cr	6.64Cr
Total Assets	1.05TCr	1.21TCr	1.5TCr	1.81TCr	1.85TCr
Liabilities
Accounts Payable, Total	45Cr	71Cr	150.52Cr	214.08Cr	173.02Cr
Accrued Expenses, Total	21Cr	24Cr	35Cr	25Cr	25Cr
Short-term Borrowings	-	-	40Cr	108.77Cr	84Cr
Current Portion of Long-Term Debt	-	63Cr	-	-	-
Current Portion of Leases	-	15.54L	4L	10.57L	10.69L
Current Income Taxes Payable	6.96Cr	4.37Cr	11Cr	18Cr	9.98Cr
Unearned Revenue Current, Total	80.31L	1.93Cr	4.91Cr	1.73Cr	1.79Cr
Other Current Liabilities	122.78Cr	116.04Cr	101.6Cr	92Cr	60Cr
Total Current Liabilities	196.7Cr	280.06Cr	342.73Cr	459.19Cr	353.82Cr
Long-Term Debt	60Cr	-	-	-	-
Long-Term Leases	-	10.16L	2L	14.34L	10.43L
Unearned Revenue Non Current	9.07Cr	8.46Cr	7.82Cr	7.14Cr	6.55Cr
Deferred Tax Liability Non Current	9.07Cr	11Cr	12Cr	11Cr	13Cr
Other Non Current Liabilities	16.73L	13.53L	10.6L	8L	5L
Total Liabilities	275.27Cr	300Cr	362.87Cr	477.48Cr	373.31Cr
Common Stock, Total	44Cr	44Cr	45Cr	45Cr	45Cr
Additional Paid In Capital	311.42Cr	314.85Cr	398.38Cr	399.91Cr	401.24Cr
Retained Earnings	411.19Cr	543.13Cr	699.8Cr	900.96Cr	1.03TCr
Treasury Stock	-	-	-9.72Cr	-11Cr	-11Cr
Comprehensive Income and Other	10Cr	10Cr	-	-	-
Total Common Equity	776.32Cr	911.69Cr	1.13TCr	1.33TCr	1.47TCr
Minority Interest	-	1.42Cr	1.51Cr	1.94Cr	2.46Cr
Total Equity	776.32Cr	913.1Cr	1.14TCr	1.34TCr	1.47TCr
Total Liabilities And Equity	1.05TCr	1.21TCr	1.5TCr	1.81TCr	1.85TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	89Cr	89Cr	92Cr	92Cr	91Cr
ECS Total Common Shares Outstanding	89Cr	89Cr	92Cr	92Cr	91Cr
Book Value / Share	8.74	10.26	12.3	14.48	16.11
Tangible Book Value	731.2Cr	866.95Cr	1.08TCr	1.29TCr	1.42TCr
Tangible Book Value Per Share	8.23	9.76	11.77	13.97	15.59
Total Debt	60Cr	63Cr	40Cr	109.02Cr	84Cr
Net Debt	-361.46Cr	-486.39Cr	-746.28Cr	-982.61Cr	-1.1TCr
Debt Equivalent Oper. Leases	4.16Cr	4.07Cr	4.2Cr	4.65Cr	4.93Cr
Minority Interest, Total (Incl. Fin. Div)	-	1.42Cr	1.51Cr	1.94Cr	2.46Cr
Equity Method Investments, Total	1.25Cr	1.32Cr	1.39Cr	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	6.12Cr	6.93Cr	7.56Cr	9.06Cr	8.05Cr
Inventories - Work In Process, Total	7.15Cr	7.66Cr	8.31Cr	16Cr	12Cr
Inventories - Finished Goods, Total	14Cr	22Cr	21Cr	23Cr	35Cr
Inventories - Others	71.93L	1.23Cr	1.79Cr	1.75Cr	1.63Cr
Buildings, Total	236.22Cr	247.33Cr	245.46Cr	291.09Cr	295.27Cr
Machinery, Total	148.82Cr	156.56Cr	164.43Cr	168.54Cr	172.76Cr
Full Time Employees	6.92T	6.63T	5.02T	5.23T	5.03T
Accumulated Allowance for Doubtful Accounts (Supple)	11Cr	12Cr	16Cr	16Cr	13Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	127.72Cr	171.92Cr	217.08Cr	282.28Cr	253.16Cr
Depreciation & Amortization - CF	26Cr	27Cr	29Cr	28Cr	28Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.29Cr	1.49Cr	1.82Cr	1.98Cr	2.22Cr
Depreciation & Amortization, Total	28Cr	29Cr	30Cr	30Cr	30Cr
Amortization of Deferred Charges, Total - (CF)	1.16Cr	1.49Cr	1.44Cr	64.6L	68.37L
(Gain) Loss From Sale Of Asset	-33.46L	-7L	-52.17L	-1L	-2L
(Gain) Loss on Sale of Investments - (CF)	-2.23Cr	-16Cr	-5.89Cr	-9.63Cr	-18Cr
Asset Writedown & Restructuring Costs	8L	4L	5L	10.89L	3L
Provision and Write-off of Bad Debts	62.43L	82.81L	3.6Cr	-30.43L	-2.22Cr
Other Operating Activities, Total	3.3Cr	3.28Cr	3.17Cr	2.17Cr	3.52Cr
Change In Accounts Receivable	1.52Cr	-18Cr	-71Cr	2.28Cr	25Cr
Change In Inventories	6Cr	-9.72Cr	-1.59Cr	-9.86Cr	-8.19Cr
Change In Accounts Payable	8.99Cr	27Cr	86Cr	48Cr	-70Cr
Change In Deferred Taxes	56.21L	69.69L	47.15L	39.43L	2.22Cr
Change in Other Net Operating Assets	3.12Cr	-62.45L	-40.69L	85.17L	1.01Cr
Cash from Operations	178.17Cr	189.43Cr	262.08Cr	346.4Cr	217.64Cr
Capital Expenditure	-43Cr	-25Cr	-24Cr	-30Cr	-17Cr
Sale of Property, Plant, and Equipment	15.4L	8L	5.28Cr	79.79L	7L
Cash Acquisitions	-	-	-	-	-
Divestitures	3.55Cr	-	-	-	-
Investment in Marketable and Equity Securities, Total	-109.62Cr	-47Cr	-138Cr	-18Cr	-195.11Cr
Other Investing Activities, Total	76.02L	4.91Cr	6.75Cr	8.21Cr	8.48Cr
Cash from Investing	-148.11Cr	-67Cr	-150.33Cr	-39Cr	-203.99Cr
Short Term Debt Issued, Total	-	-	40Cr	109.54Cr	144.17Cr
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	40Cr	109.54Cr	144.17Cr
Short Term Debt Repaid, Total	-	-	-75.2L	-40Cr	-140.56Cr
Long-Term Debt Repaid, Total	-172	-18.18L	-17.92L	-14.76L	-13.99L
Total Debt Repaid	-172	-18.18L	-93.12L	-40Cr	-140.7Cr
Issuance of Common Stock	140.5Cr	5Cr	9.72Cr	1.42Cr	-
Repurchase of Common Stock	-	-	-	-3.57Cr	-2.22Cr
Common Dividends Paid	-100.88Cr	-41Cr	-61Cr	-82Cr	-121.77Cr
Common & Preferred Stock Dividends Paid	-100.88Cr	-41Cr	-61Cr	-82Cr	-121.77Cr
Other Financing Activities, Total	-2.24Cr	-	-	-	-
Cash from Financing	37Cr	-36Cr	-12Cr	-15Cr	-120.51Cr
Net Change in Cash	67Cr	86Cr	100Cr	291.9Cr	-106.86Cr
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	93Cr	117.66Cr	126.44Cr	165Cr	146.4Cr
Levered Free Cash Flow	91Cr	101.23Cr	163.98Cr	227.8Cr	129.64Cr
Unlevered Free Cash Flow	93Cr	103.41Cr	165.89Cr	228.9Cr	131.34Cr
Change In Net Working Capital	-21Cr	6.58Cr	-17Cr	-47Cr	35Cr
Net Debt Issued / Repaid	-172	-18.18L	39Cr	69Cr	3.47Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	9.03	9.22	10.39	10.88	8.28
Return on Total Capital	11.51	11.52	13.1	13.75	10.1
Return On Equity %	18.42	20.33	21.2	22.87	18.06
Return on Common Equity	18.42	20.37	21.23	22.87	18.05
Margin Analysis
Gross Profit Margin %	81.67	83.27	82.91	81.52	79.21
SG&A Margin	53.52	52.82	49.76	45.36	42.25
EBITDA Margin %	26.95	25.67	28.41	32.94	34.01
EBITA Margin %	22.68	22.09	25.26	30.07	30.53
EBIT Margin %	22.47	21.89	25.05	29.87	30.26
Income From Continuing Operations Margin %	20.72	22.5	24.14	29.28	31.64
Net Income Margin %	20.72	22.53	24.13	29.24	31.58
Net Avail. For Common Margin %	20.72	22.53	24.13	29.24	31.58
Normalized Net Income Margin	14.54	14.82	16.7	20.82	21.38
Levered Free Cash Flow Margin	14.74	13.27	18.23	23.6	16.17
Unlevered Free Cash Flow Margin	15.08	13.55	18.44	23.71	16.38
Asset Turnover
Asset Turnover	0.64	0.67	0.66	0.58	0.44
Fixed Assets Turnover	2	2.47	3.05	3.34	2.85
Receivables Turnover (Average Receivables)	3.01	3.61	3.57	3.42	3.17
Inventory Turnover (Average Inventory)	3.66	3.9	4.01	4.05	3.15
Short Term Liquidity
Current Ratio	3.34	2.9	3.26	3.1	4.16
Quick Ratio	3.18	2.75	3.13	2.99	3.99
Operating Cash Flow to Current Liabilities	0.91	0.68	0.76	0.75	0.62
Days Sales Outstanding (Average Receivables)	121.58	100.97	102.33	106.64	115.32
Days Outstanding Inventory (Average Inventory)	99.88	93.5	91.06	90.18	116.31
Average Days Payable Outstanding	151.95	153.83	287.97	353.45	405.85
Cash Conversion Cycle (Average Days)	69.51	40.64	-94.59	-156.62	-174.22
Long Term Solvency
Total Debt/Equity	7.76	6.9	3.53	8.15	5.69
Total Debt / Total Capital	7.2	6.46	3.41	7.54	5.39
LT Debt/Equity	7.76	0.01	0	0.01	0.01
Long-Term Debt / Total Capital	7.2	0.01	0	0.01	0.01
Total Liabilities / Total Assets	26.18	24.73	24.22	26.32	20.22
EBIT / Interest Expense	41.94	47.87	74.12	163.99	88.94
EBITDA / Interest Expense	50.31	56.15	84.11	180.95	100.03
(EBITDA - Capex) / Interest Expense	37.3	49.04	76.1	163.8	93.64
Total Debt / EBITDA	0.36	0.32	0.16	0.34	0.31
Net Debt / EBITDA	-2.18	-2.48	-2.92	-3.09	-4.03
Total Debt / (EBITDA - Capex)	0.49	0.37	0.17	0.38	0.33
Net Debt / (EBITDA - Capex)	-2.93	-2.84	-3.22	-3.41	-4.3
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.17	23.77	17.9	7.32	-16.96
Gross Profit, 1 Yr. Growth %	-13.64	26.2	17.39	5.52	-19.31
EBITDA, 1 Yr. Growth %	-18.35	17.58	30.17	24.19	-14.38
EBITA, 1 Yr. Growth %	-23.44	20.17	34.43	27.52	-15.82
EBIT, 1 Yr. Growth %	-23.15	20.6	34.91	27.94	-15.88
Earnings From Cont. Operations, 1 Yr. Growth %	-21.3	34.45	26.47	30.18	-10.27
Net Income, 1 Yr. Growth %	-21.3	34.6	26.27	30.04	-10.32
Normalized Net Income, 1 Yr. Growth %	-21.86	26.15	32.83	33.79	-14.75
Diluted EPS Before Extra, 1 Yr. Growth %	-23.12	24.84	25.13	28.87	-10.39
Accounts Receivable, 1 Yr. Growth %	-1.12	7.44	30.58	-2.41	-18.84
Inventory, 1 Yr. Growth %	-17.74	34.9	4.23	25.19	16.12
Net Property, Plant and Equip., 1 Yr. Growth %	4.07	-3.4	-5.86	2.32	-7.4
Total Assets, 1 Yr. Growth %	21.36	15.36	23.49	21.11	1.74
Tangible Book Value, 1 Yr. Growth %	30.54	18.57	25.14	18.69	10.47
Common Equity, 1 Yr. Growth %	27.17	17.44	24.36	17.75	10.13
Cash From Operations, 1 Yr. Growth %	-17.04	6.32	38.35	32.17	-37.17
Capital Expenditures, 1 Yr. Growth %	-21.38	-42.2	-1.88	23.8	-42.21
Levered Free Cash Flow, 1 Yr. Growth %	-30.2	11.37	61.99	38.92	-43.09
Unlevered Free Cash Flow, 1 Yr. Growth %	-29.65	11.24	60.42	37.99	-42.62
Dividend Per Share, 1 Yr. Growth %	-63.41	51.11	29.41	47.73	60.77
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-7.52	4.86	20.8	12.48	-5.6
Gross Profit, 2 Yr. CAGR %	-9.24	4.4	21.72	11.3	-7.73
EBITDA, 2 Yr. CAGR %	-9.79	-1.89	23.86	27.26	3.19
EBITA, 2 Yr. CAGR %	-13.97	-3.93	27.27	31.07	3.69
EBIT, 2 Yr. CAGR %	-13.85	-3.73	27.56	31.38	3.74
Earnings From Cont. Operations, 2 Yr. CAGR %	-13.01	2.86	30.4	28.31	8.08
Net Income, 2 Yr. CAGR %	-13.01	2.92	30.37	28.14	7.99
Normalized Net Income, 2 Yr. CAGR %	-12.8	-0.71	29.45	33.31	6.8
Diluted EPS Before Extra, 2 Yr. CAGR %	-14.03	-2.03	24.98	26.99	7.46
Accounts Receivable, 2 Yr. CAGR %	-1.78	3.07	18.45	12.88	-11
Inventory, 2 Yr. CAGR %	-6.45	5.34	18.58	14.23	20.57
Net Property, Plant and Equip., 2 Yr. CAGR %	5.64	0.26	-4.64	-1.86	-2.66
Total Assets, 2 Yr. CAGR %	16.13	18.32	19.36	22.3	11
Tangible Book Value, 2 Yr. CAGR %	21.3	24.41	21.81	21.87	14.51
Common Equity, 2 Yr. CAGR %	19.26	22.21	20.85	21.01	13.88
Cash From Operations, 2 Yr. CAGR %	2.1	-6.08	21.28	35.23	-8.87
Capital Expenditures, 2 Yr. CAGR %	-19.81	-32.59	-24.69	10.22	-15.41
Levered Free Cash Flow, 2 Yr. CAGR %	146.14	-11.83	34.32	50.01	-11.09
Unlevered Free Cash Flow, 2 Yr. CAGR %	132.91	-11.54	33.59	48.78	-11.02
Dividend Per Share, 2 Yr. CAGR %	-39.51	-25.65	39.84	38.27	54.11
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3	1.92	9.04	16.13	1.66
Gross Profit, 3 Yr. CAGR %	1.65	1.3	8.56	16.06	-0.02
EBITDA, 3 Yr. CAGR %	3.45	-1.37	7.9	24.05	11.56
EBITA, 3 Yr. CAGR %	0.7	-3.73	7.55	27.45	13.14
EBIT, 3 Yr. CAGR %	0.88	-3.63	7.73	27.69	13.24
Earnings From Cont. Operations, 3 Yr. CAGR %	1.43	0.58	10.2	30.32	13.89
Net Income, 3 Yr. CAGR %	1.44	0.61	10.18	30.26	13.77
Normalized Net Income, 3 Yr. CAGR %	0.04	-1.37	9.4	30.88	14.85
Diluted EPS Before Extra, 3 Yr. CAGR %	0.44	-2.65	6.3	26.27	13.06
Accounts Receivable, 3 Yr. CAGR %	4.01	1.2	11.53	11.04	1.13
Inventory, 3 Yr. CAGR %	4.72	5.69	4.97	20.74	14.86
Net Property, Plant and Equip., 3 Yr. CAGR %	10.62	2.54	-1.82	-2.37	-3.74
Total Assets, 3 Yr. CAGR %	16.43	15.87	20.02	19.94	15.02
Tangible Book Value, 3 Yr. CAGR %	22.15	20.38	24.65	20.76	17.95
Common Equity, 3 Yr. CAGR %	20.82	18.65	22.92	19.8	17.27
Cash From Operations, 3 Yr. CAGR %	14.44	3.49	6.86	24.81	4.74
Capital Expenditures, 3 Yr. CAGR %	-16.81	-28.1	-23.6	-11.12	-11.12
Levered Free Cash Flow, 3 Yr. CAGR %	128.96	88.96	7.99	35.83	8.59
Unlevered Free Cash Flow, 3 Yr. CAGR %	127.32	82.06	7.88	35.04	8.3
Dividend Per Share, 3 Yr. CAGR %	-23.37	-17.93	-10.56	42.42	45.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.35	10.28	9.78	6.02	2.93
Gross Profit, 5 Yr. CAGR %	9.64	9.77	9.25	5.19	1.73
EBITDA, 5 Yr. CAGR %	14.42	11.12	11.23	9.27	6.03
EBITA, 5 Yr. CAGR %	13.04	9.76	10.66	8.98	6.04
EBIT, 5 Yr. CAGR %	13.4	9.96	10.81	9.09	6.12
Earnings From Cont. Operations, 5 Yr. CAGR %	13.33	12.94	12.15	10.87	9.34
Net Income, 5 Yr. CAGR %	13.22	12.97	12.15	10.83	9.3
Normalized Net Income, 5 Yr. CAGR %	13.52	11.37	10.9	11.26	8.35
Diluted EPS Before Extra, 5 Yr. CAGR %	11.7	10.3	9.62	8.27	6.76
Accounts Receivable, 5 Yr. CAGR %	12.58	8.89	9.56	5.72	1.9
Inventory, 5 Yr. CAGR %	10.29	12.94	10.06	9.02	10.95
Net Property, Plant and Equip., 5 Yr. CAGR %	18.32	12.38	4.24	0.76	-2.16
Total Assets, 5 Yr. CAGR %	24.01	19.45	17.59	18.4	16.33
Tangible Book Value, 5 Yr. CAGR %	26.13	21.57	22.01	20.98	20.49
Common Equity, 5 Yr. CAGR %	23.81	20.04	20.83	19.59	19.22
Cash From Operations, 5 Yr. CAGR %	22.52	15.71	17.13	15.18	0.27
Capital Expenditures, 5 Yr. CAGR %	1.64	-5.15	-20.06	-14.7	-20.43
Levered Free Cash Flow, 5 Yr. CAGR %	213.2	15.4	84.98	72.3	-0.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	256.64	15.89	83.77	67.94	-0.12
Dividend Per Share, 5 Yr. CAGR %	-8.46	-1.41	-2.52	1.11	11.19